| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 8,227 | 8,514 | 8,592 | 10,326 | | Cost of Revenue | 6,264 | 6,285 | 6,305 | 7,849 | | | Gross Profit | 1,963 | 2,229 | 2,287 | 2,477 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 3,771 | 4,179 | 3,677 | 4,369 | | Non Recurring | 150 | 1,282 |
-
| 2,841 | | Others | 255 | 252 | 232 | 294 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (2,213) | (3,484) | (1,622) | (5,027) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2 | 44 | 9 | (2,234) | | Earnings Before Interest And Taxes | (2,261) | (3,440) | (1,613) | (7,261) | | Interest Expense | (21) | 16 | 5 | 327 | | Income Before Tax | (2,240) | (3,456) | (1,618) | (7,588) | | Income Tax Expense | 15 | 40 | 40 | 25 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (2,255) | (3,496) | (1,658) | (7,613) | | | Non-recurring Events | | Discontinued Operations | (103) | 164 | 60 | (1,023) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (2,358) | (3,332) | (1,598) | (8,636) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($2,358) | ($3,332) | ($1,598) | ($8,636) |
|
0.51% Nasdaq 0.00%
Income Statement
